OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, July 30th USMM, GNAU, MGRN, DENN, RGBI, ETLC

Our Stocks to Watch today include U.S. Mine Makers Inc. (OTC: USMM), General Automotive Co. (OTCBB: GNAU), Monogram Energy Inc. (OTC: MGRN), Denny’s Corp. (Nasdaq: DENN), ReGen Biologics Inc. (OTC: RGBI), Etelcharge.com Inc. (OTCBB: ETLC)

U.S. MINE MAKERS INCORPORATED (OTC: USMM)

Company Profile:

U.S. Mine Makers, Inc. is a US-based company engaged in "eco friendly" mining and processing of precious metals in Idaho, Nevada and Canada. The Company processes ore concentrate and hard rock ore to recover residual gold, platinum, rhodium and other precious metals from waste rocks of old abandoned mines. The Company`s goal is to process ore in a safe and economical manner, with little or no environmental impact.

GENERAL AUTOMOTIVE COMPANY (OTCBB: GNAU)

"Up 16.00% in morning trading"

Company Profile:

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)

"Up 56.67% in morning trading"

Company Profile:

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

DENNY'S CORPORATION (NASDAQ: DENN)

"Up 3.54% in morning trading"

Denny's Corporation, through its subsidiaries, engages in the ownership and operation of family-style restaurants primarily in the United States. The company owns and operates its restaurants under the Denny's brand name. Its restaurants offer traditional American-style food. As of December 26, 2007, Denny's Corporation operated 1,546 restaurants, including 1,152 franchised/licensed restaurants and 394 company-owned and operated restaurants. The company was founded in 1980 and is headquartered in Spartanburg, South Carolina.

REGEN BIOLOGICS INCORPORATED (OTCBB: RGBI)

"Up 25.00% in morning trading"

ReGen Biologics is an orthopedic products company that develops, manufactures and markets innovative tissue growth and repair products for U.S. and global markets. ReGen's patented collagen scaffold technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. ReGen’s first approved product using its collagen scaffold technology is the Menaflex™ collagen meniscus implant, which is cleared for sale in Europe and other countries and marketed through ReGen’s European subsidiary, ReGen Biologics AG. The CMI® name was used during the research and development phase of the Company’s collagen meniscus implant device, and it will continue to be seen in numerous scientific publications and clinical references. ReGen continues to pursue FDA clearance of the Menaflex device in the United States. ReGen Biologics was founded in 1987 and is headquartered in Hackensack, New Jersey.

RGBI News:

July 28 - ReGen Biologics Closes $2.5 Million Private Placement and Announces New 510(k) Submission to the FDA

ReGen Biologics (OTC: RGBI) announced that it has completed a $2.5 million private placement of convertible notes and it has submitted a new 510(k) seeking FDA clearance of its collagen scaffold device for reinforcement and repair of meniscus tissue.

The Company expects net proceeds from the private placement combined with existing cash will enable it to operate well into the fourth quarter 2008. The Company designed the financing transaction to realize sufficient capital to operate through the expected timeframe required for a decision from the FDA on its recent 510(k) submission.

The Company recently announced publication of long-term clinical results of its meniscus device in the July 2008 issue of The Journal of Bone and Joint Surgery (JBJS), which reports on the ReGen 300+ patient U.S. Multi-center Clinical Trial. For more information and to obtain a free download of the published article, please visit the Company’s website at www.regenbio.com.

Under the terms of the financing, the Company sold approximately $2.5 million in aggregate principal amount of unsecured convertible notes. The notes accrue interest at an annual rate of 8% and become due and payable on July 24, 2009. At the option of the holders, the notes may be converted into Series F Convertible Preferred Stock ("Series F Stock") at a price of $15 per share or into the common stock of the Company at a price of $0.15 per share if the Series F Stock has previously converted to common stock. In connection with the financing, the Company issued five year warrants equal to 25% of the shares into which the notes may convert, exercisable at a price of $1.00 per share of Series F Stock or $0.01 per share if the Series F Stock is converted to common stock.

Each share of Series F Stock into which the notes may convert will automatically convert into 100 shares of common stock upon amendment of the Company’s certificate of incorporation or upon a reverse stock split of the common stock, in each case making available adequate shares of common stock to support such conversion. At such time, each warrant share will convert into the right to acquire 100 shares of common stock. The conversion of the notes and the Series F Stock are subject to anti-dilution rights. The Company has agreed to register the common stock into which the preferred shares will convert on one or more registration statements to be filed with the SEC upon request by the investors.

ETELCHARGE.COM INCORPORATED (OTCBB: ETLC)

"Up 36.36% in morning trading"

eTelcharge.com, Inc., a development stage company, provides credit card processing services for merchants in the United States. It develops the initial telephone billing payment option that enables the customers of online merchants with the ability to charge their Internet purchases to their local telephone bill, rather than to a credit card. The company was founded in 1999 and is based in Desoto, Texas.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has received one hundred fourty five thousand free trading share from a third party (Tom Yarbray) for USMM advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by a third party (StockPromoters.com Consultants, LLC) for ETLC advertising and promotional services. OTCPicks is receiving twelve thousand shares from a third party (Windermere Capital Partners) for GNAU advertising and promotion services. OTCPicks.com has received fifty thousand free trading shares from a non-controlling third party (Microcap Management) for MGRN advertising and promotional services.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.